Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
Technology
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
📰 Source Attribution: This article is based on reporting by
WIRED.
HotTakeDaily summarises and links to original journalism. Full credit to original reporters and publishers.